ClinConnect ClinConnect Logo
Search / Trial NCT06143111

A Comparison of Thoracic Electrical Bioimpedance and FloTrac/Vigileo

Launched by RENJI HOSPITAL · Nov 19, 2023

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying two methods for monitoring a patient’s fluid status during surgery, specifically for those undergoing laparoscopic surgery for gastrointestinal tumors. The researchers want to compare a traditional method called FloTrac, which involves a small device placed in the body to measure heart function and fluid levels, with a newer, non-invasive method called Thoracic Electrical Bioimpedance. This new method uses sensors on the skin to gather similar information without needing any invasive procedures.

To be eligible for this trial, participants should be between the ages of 18 and 65 and be scheduled for elective laparoscopic surgery. They should also have a body mass index (BMI) between 18 and 30 and not have certain health issues, such as severe heart or liver problems. If chosen to participate, individuals can expect to have their heart function and fluid responsiveness measured using both techniques during their surgery. It's important to note that this trial is not yet recruiting participants, so there may be a wait before it starts.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18≤ Age ≤65.
  • patients undergoinglaparoscopic elective surgery for gastrointestinal tumors under general anesthesia
  • 18 kg/m2≤BMI≤30 kg/m2
  • ASA classification I-III
  • Patients signed informed consent form
  • Exclusion Criteria:
  • Arrhythmias
  • The patient is diagnosed with severe cardiovascular disease(pulmonary arterial hypertension、left ventricular ejection fraction\< 50%、aortic aneurysm、extensive peripheral arterial occlusive disease,、significant valvulopathy)
  • Severe heart failure (METS\<4)
  • The patient is diagnosed with severe hepatic dysfunction (ChildePugh class C)
  • The patient is diagnosed with severe renal dysfunction (undergoing dialysis before surgery)
  • There is an infectious lesion on the skin or subcutaneous tissue where the non-invasive electrode piece is placed
  • History of allergy to anesthetic drugs
  • Weight\<40kg
  • Allergies to 6% hydroxyethyl starch, Fresenius Kabi, Deutschland

About Renji Hospital

Renji Hospital, a prestigious medical institution affiliated with Shanghai Jiao Tong University School of Medicine, is dedicated to advancing healthcare through innovative clinical research. With a strong emphasis on patient-centered care, Renji Hospital conducts a wide range of clinical trials across various therapeutic areas, harnessing cutting-edge technology and evidence-based practices. The hospital's multidisciplinary team of experienced researchers and medical professionals collaborates closely to ensure rigorous study design and execution, aiming to contribute significantly to medical knowledge and improve treatment outcomes for patients worldwide.

Locations

Pudong, Shanghai, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported